M A Nalesnik
Overview
Explore the profile of M A Nalesnik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
2071
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ezzelarab M, Zhang H, Guo H, Lu L, Zahorchak A, Wiseman R, et al.
Am J Transplant
. 2015 Dec;
16(7):1999-2015.
PMID: 26700196
The ability of regulatory T cells (Treg) to prolong allograft survival and promote transplant tolerance in lymphodepleted rodents is well established. Few studies, however, have addressed the therapeutic potential of...
2.
Miller R, Covington S, Taranto S, Carrico R, Ehsan A, Friedman B, et al.
Am J Transplant
. 2014 Nov;
15(1):259-64.
PMID: 25376342
The detection and management of potential donor-derived infections is challenging, in part due to the complexity of communications between diverse labs, organ procurement organizations (OPOs), and recipient transplant centers. We...
3.
Engels E, Castenson D, Pfeiffer R, Kahn A, Pawlish K, Goodman M, et al.
Am J Transplant
. 2014 Apr;
14(6):1376-82.
PMID: 24712385
Transmission of cancer is a life-threatening complication of transplantation. Monitoring transplantation practice requires complete recording of donor cancers. The US Scientific Registry of Transplant Recipients (SRTR) captures cancers in deceased...
4.
Lunz J, Ruppert K, Cajaiba M, Isse K, Bentlejewski C, Minervini M, et al.
Am J Transplant
. 2011 Oct;
12(1):171-82.
PMID: 21992553
C4d-assisted recognition of antibody-mediated rejection (AMR) in formalin-fixed paraffin-embedded tissues (FFPE) from donor-specific antibody-positive (DSA+) renal allograft recipients prompted study of DSA+ liver allograft recipients as measured by lymphocytotoxic crossmatch...
5.
Nalesnik M, Woodle E, Dimaio J, Vasudev B, Teperman L, Covington S, et al.
Am J Transplant
. 2011 Jun;
11(6):1140-7.
PMID: 21645251
The continuing organ shortage requires evaluation of all potential donors, including those with malignant disease. In the United States, no organized approach to assessment of risk of donor tumor transmission...
6.
Ison M, Nalesnik M
Am J Transplant
. 2011 Mar;
11(6):1123-30.
PMID: 21443676
Several recent donor-to-recipient disease transmissions have highlighted the importance of this rare complication of solid organ transplantation. The epidemiology of donor-derived disease transmissions in the United States has been described...
7.
Ragni M, Moore C, Soadwa K, Nalesnik M, Zajko A, Cortese-Hassett A, et al.
Haemophilia
. 2010 Aug;
17(1):103-11.
PMID: 20722744
Hepatitis C virus (HCV) is the major cause of liver disease in haemophilia. Few data exist on the proportion with liver fibrosis in this group after long-term HCV and HIV...
8.
Yoshida J, Ozaki K, Nalesnik M, Ueki S, Castillo-Rama M, Faleo G, et al.
Am J Transplant
. 2010 Mar;
10(4):763-772.
PMID: 20199500
I/R injury is a major deleterious factor of successful kidney transplantation (KTx). Carbon monoxide (CO) is an endogenous gaseous regulatory molecule, and exogenously delivered CO in low concentrations provides potent...
9.
Ragni M, Nalesnik M, Schillo R, Dang Q
Haemophilia
. 2009 Apr;
15(2):552-8.
PMID: 19347994
The impact of highly active antiretroviral therapy (HAART) on progression to end-stage liver disease (ESLD) in human immunodeficiency virus (HIV)/hepatitis C virus (HCV) co-infection remains controversial. We studied 157 HCV+...
10.
Habib S, Nalesnik M, Ahmad J, BuchBarker D, Shakil A
Bone Marrow Transplant
. 2007 Mar;
39(9):573-5.
PMID: 17369864
No abstract available.